Metabolic Alteration in Presymptomatic and Symptomatic ALS Study (MAPS ALS Study)
症状前和症状性 ALS 研究中的代谢改变(MAPS ALS 研究)
基本信息
- 批准号:10644489
- 负责人:
- 金额:$ 22.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:ALS patientsAdultAffectAmyotrophic Lateral SclerosisAreaBiological MarkersBiometryBloodBody CompositionBody WeightBody mass indexC9ORF72Cessation of lifeClassificationClinicClinicalClinical Course of DiseaseCohort StudiesControl GroupsDataData SetDeglutition DisordersDevelopmentDiagnosisDiagnosticDifferential DiagnosisDiseaseDisease ProgressionEarly DiagnosisEarly InterventionEarly identificationEarly treatmentEnergy IntakeEnergy MetabolismEpidemiologyFamilyFatty acid glycerol estersFoundationsGenetic Predisposition to DiseaseGenetic RiskGoalsHeightIndividualKnowledgeLearningLipidsLongitudinal cohort studyMachine LearningMeasuresMentored Patient-Oriented Research Career Development AwardMetabolicMetabolic MarkerMetabolismMotor Neuron DiseaseMotor NeuronsMuscle WeaknessNatural HistoryNerve DegenerationNeurodegenerative DisordersNeuronal DysfunctionNewly DiagnosedOxidative StressParticipantPathogenesisPathogenicityPatternPlasmaPopulationPositioning AttributePrimary Lateral SclerosisProbabilityProductionProspective, cohort studyPublic HealthReportingResearchResearch PersonnelResearch TrainingRespiratory FailureRestSamplingSigns and SymptomsStressSymptomsTechniquesUnited StatesUniversitiesValidationVariantWeightalgorithm trainingbiobankbiomarker developmentclinical applicationcohortcomparison controldiagnostic biomarkerdrug developmentearly detection biomarkerseffective therapyfamilial amyotrophic lateral sclerosisfatty acid oxidationindexinginsightlipid mediatorlipid metabolismlipidomelipidomicslongitudinal, prospective studymachine learning algorithmmetabolic profilemitochondrial dysfunctionmutation carriernovelnovel diagnosticsphenotypic biomarkerpredictive markerpredictive toolspreventskillssporadic amyotrophic lateral sclerosissupervised learningtherapeutic targettotal energy expenditure
项目摘要
Project Summary/Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating disease with upper and lower motor neuron dysfunction
and degeneration leading to progressive weakness and death due to dysphagia and respiratory failure. There
is an urgent need to develop effective treatment to stop or reverse the progression. However, this has proven
to be challenging due to an incomplete understanding of the pathogenesis and delay in the diagnosis of ALS.
There are data supporting biomarkers of mitochondrial dysfunction, energy expenditure (EE) and body
weight/composition as early indices of incident clinical disease. Identification of these markers could facilitate
earlier intervention to prevent or delay disease progression as well as provide information on therapeutic
targets in individuals at genetic risk for ALS. I hypothesize that 1) the plasma lipid mediators (lipidome) can
accurately differentiate ALS, and primary lateral sclerosis (PLS) subjects from controls 2) body
weight/composition and EE differ between C9orf72+ ALS, presymptomatic C9orf72 mutation carriers
(C9orf72+ Pre-ALS) participants and controls 3) certain metabolic profiles will predict symptom onset in
C9orf72+ Pre-ALS participants. In this proposed study, I will 1) investigate the plasma lipidome profile of ALS
and PLS subjects to identify lipid mediators as diagnostic biomarkers in motor neuron disease, 2) evaluate
body weight/composition and EE in C9orf72+ ALS and Pre-ALS to measure changes in energy metabolism
in advance of and through the course of disease, and 3) follow a cohort of C9orf72+ Pre-ALS participants
annually to track the emergence of ALS symptoms and signs to determine if certain metabolic profiles predict
symptom onset in this genetically predisposed population. Successful completion of this project would provide
key data to 1) establish the lipidome profile as a diagnostic biomarker for ALS and PLS, and 2) provide the
foundation for a prospective cohort study of C9orf72+ Pre-ALS individuals to determine if the lipidome profile
and metabolic markers (body composition, EE) could serve as a premonitory marker for the phenotypic
conversion from asymptomatic to symptomatic ALS. This K23 award will provide the support needed to
complete the proposed research and to further develop my expertise in three major scientific areas, 1)
expertise in lipidome data production and analysis, 2) expertise in metabolism and EE, and 3) mastery of
advanced statistical techniques for clinical applications. I will leverage the research training I receive in the
K23 to lead a longitudinal cohort study of pre-ALS participants to determine the relationship between
metabolic changes and clinical manifestations of ALS. My overarching goal is to identify early diagnostic
biomarkers and therapeutic targets for the development of an effective treatment to prevent or delay the
progression of ALS.
项目总结/摘要
肌萎缩侧索硬化症(amyotrophiclateralsclerosis,ALS)是一种以上、下运动神经元功能障碍为主要表现的破坏性疾病
和变性,导致进行性虚弱和由于吞咽困难和呼吸衰竭而死亡。那里
迫切需要开发有效的治疗方法来阻止或逆转进展。然而,这已经证明,
由于对ALS发病机制的不完全理解和诊断延迟,因此具有挑战性。
有数据支持线粒体功能障碍、能量消耗(EE)和身体功能障碍的生物标志物。
重量/组成作为偶发临床疾病的早期指标。这些标记的识别可以促进
早期干预,以预防或延缓疾病进展,并提供治疗信息
有ALS遗传风险的个体中的靶点。我假设1)血浆脂质介质(脂质体)可以
准确区分ALS和原发性侧索硬化症(PLS)受试者与对照组2)身体
C9 orf 72 + ALS、症状前C9 orf 72突变携带者之间的体重/组成和EE不同
(C9 orf 72 + Pre-ALS)参与者和对照者3)某些代谢谱将预测C9 orf 72 + Pre-ALS患者的症状发作。
C9 orf 72+前ALS参与者。在这项拟议的研究中,我将1)研究ALS的血浆脂质体分布
和PLS受试者以鉴定脂质介质作为运动神经元疾病的诊断生物标志物,2)评估
C9 orf 72 + ALS和Pre-ALS中的体重/组成和EE,以测量能量代谢的变化
在疾病之前和整个疾病过程中,以及3)跟踪C9 orf 72 + Pre-ALS参与者的队列
每年跟踪ALS症状和体征的出现,以确定某些代谢特征是否预测
在这个遗传易感人群中出现症状。该项目的成功完成将为
关键数据1)建立脂质组谱作为ALS和PLS的诊断生物标志物,和2)提供
为C9 orf 72 + Pre-ALS个体的前瞻性队列研究奠定了基础,以确定脂质组特征是否
代谢指标(体成分,EE)可以作为表型的前兆标志物
从无症状到有症状的ALS的转变。K23将提供必要的支持,
完成拟议的研究,并进一步发展我在三个主要科学领域的专业知识,1)
脂质组数据生成和分析方面的专业知识,2)代谢和EE方面的专业知识,以及3)掌握
临床应用的先进统计技术。我将充分利用我在
K23领导一项对ALS前参与者的纵向队列研究,以确定
代谢变化和ALS的临床表现。我的首要目标是找出早期诊断
生物标志物和治疗靶点,用于开发有效的治疗以预防或延迟
ALS的进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ikjae Lee其他文献
Ikjae Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 22.96万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 22.96万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 22.96万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 22.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 22.96万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 22.96万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 22.96万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 22.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 22.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 22.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)